The largest database of trusted experimental protocols

Cd11b clone m1 70

Manufactured by Thermo Fisher Scientific
Sourced in United States

CD11b (clone M1/70) is a monoclonal antibody that binds to the integrin alpha M (CD11b) molecule, which is expressed on the surface of various immune cells, including monocytes, macrophages, granulocytes, and natural killer cells. This antibody can be used for the identification and characterization of these cell types in research applications.

Automatically generated - may contain errors

44 protocols using cd11b clone m1 70

1

Identification and Quantification of Muscle Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions from muscle were prepared by collagenase II (Worthington Biochemical Corp, Lakewood, NJ, USA) digestion followed by staining with fluorochrome-conjugated antibodies.
Antibodies used: (1) Gr1 Clone RB6-8C5 (eBioscience, ThermoFisher, Waltham, MA, USA, Cat#48-5931-82); (2) F4/80 Clone BM8 (Invitrogen, Cat# 11-4801-82); (3) CD11b Clone M1/70 (Invitrogen, ThermoFisher, Waltham, MA, USA, Cat#17-0112-81); (4) Siglec-F Clone E50-2440 (RUO), (BD BioSciences, ThermoFisher, Waltham, MA, USA, Cat# 552126); (5) CD206 Clone C068C2 (BioLegend, San Diego, CA, USA, Cat#141701) and live dead stain (eBioscience). Data acquisition was performed on a FACS Aria or Fortessa (BD Biosciences). UltraComp eBeads (Cat#01333342, Invitrogen) were used to generate single-stain controls. Data was analyzed using FlowJo software (version 10.2) and gating strategies as previously described [39 (link)] to discriminate against dead cells, debris, and doublets were utilized. M1 macrophages were defined as Gr1low-med, F4/80+, and CD11b+.
+ Open protocol
+ Expand
2

Characterization of Middle Ear Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies, labeled with appropriate fluorochromes were purchased from BD Biosciences (San Jose, CA, USA), Invitrogen (Carlsbad, CA, USA), or Life Technologies (Carlsbad, CA USA). Cells isolated from the middle ear effusion were stained for Ly6G (clone 1A8), Ly6C (clone AL-21), NK1.1 (clone PK136), CD45R (B220 clone RA3-6B2), CD11c (clone HL3) (BD Biosciences, San Jose, CA, USA), CD11b (clone M1/70) (Invitrogen, Carlsbad, CA, USA), and live/dead markers, including nucleic acid Sytox dyes and amine-reactive dyes (Life Technologies, Carlsbad, CA USA). This allowed discrimination of neutrophil subsets based on staining of Ly6G: CD11b+ CD45R− NK1.1− Ly6Ghi mature cells; CD11b+ CD45R− NK1.1− Ly6Gint immature cells. Macrophages were identified as CD11b± CD45R− NK1.1− Ly6G− Ly6C+; and dendritic cells as CD11c+48 (link). Cells undergoing phagocytosis were identified as positive for surface markers of subsets as above and also positive for the bacterial reporter GFP. Cells were analyzed on an LSRII flow cytometer (BD Biosciences, San Jose, CA, USA) and analysis was performed using FlowJo (BD Biosciences, San Jose, CA, USA). All samples were analyzed the same day as the samples were collected and cell identification by sequential gating performed on live cells with doublet discrimination.
+ Open protocol
+ Expand
3

Tumor-Infiltrating Lymphocyte Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor-infiltrating lymphocyte phenotypes were analyzed using standard flow cytometry techniques. In short, excised tumors were mechanically disrupted into single-cell suspensions by grinding over a 40-µm nylon mesh filter into phosphate-buffered saline (PBS). Cells were then pelleted and immediately stained for flow cytometry using standard methodologies. Antibodies for these studies were obtained from BD Biosciences (San Jose, California, USA), Biolegend (San Diego, California, USA), and Invitrogen (Waltham, Massachusetts, USA) and included: Ly6c (clone HK1.4), CD45 (clone 30-F11), CD11b (clone M1/70), CD11c (clone HL3), Ly6G (clone 1A8), F4/80 (T45-2342), NK1.1 (clone PK136), I-Ab (clone M5/114.15.2), IL-17R (clone A7R34), CD3 (clone KT3.1.1), NKp46 (clone 29A1.4), CD49a (clone Ha31/8), CD49b (clone HMa2), CD25 (clone PC61), CD4 (clone GK1.5), B220 (clone RM2619), CD200RI (clone 0×110), and CD8a (clone 53–6.7).
+ Open protocol
+ Expand
4

Characterization of Tumor-Infiltrating Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions from spleens and lymph nodes were prepared as described.6 (link) TIL were isolated from pooled tumors as described.26 (link) All flow cytometry experiments were performed at least 3 times. Single cell suspensions were incubated with mouse Fc receptor binding inhibitor for 10 minutes before staining with antibodies to CD45 (clone 30-F11), CD3 (clone 145-2C11), CD4 (clone GK1.5), CD8 (clone 53-6.7), CD19 (clone eBio1D3), CD86 (clone GL1), CD11b (clone M1/70), Gr-1 (clone RB6-8C5), CD69 (clone H1.2F3), CD44 (clone IM9), CD62L (clone MEL-14), and CD11c (clone N418; all from eBioscience, San Diego, CA) for 30 minutes. Flow cytometry was performed using FACS Calibur (BD Biosciences) and the lymphocyte population was selected by gating CD45+ cells. The data were analyzed using Flow Jo software (Tree Star, Ashland, OR). For tetramer staining, 10 μL of PE labeled HLA-A*02:01 Human HPV16 E7 tetramer (NIH Tetramer Core Facility) was added to 200 μL mouse lymphocyte suspension (1×106 cells per tube). After incubation for 30 minutes, cells were centrifuged and resuspended in phosphate-buffered saline with 1% paraformaldehyde and then analyzed by flow cytometry. PE labeled HLA-A*02:01 human mesothelin tetramer (NIH Tetramer Core Facility) was used as control.
+ Open protocol
+ Expand
5

Isolation and Characterization of Circulating Immune Cells and Platelets from Murine Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from P14 mice by cardiac puncture at time of euthanasia in 50 mM EDTA containing Futan-75 to prevent complement activation. Collected samples were centrifuged for 10 min at 600 g. Supernatant was removed, and pellets resuspended in 1 mL citrate buffer containing 50 ng/mL PGE2 to prevent platelet activation. The resuspended samples were centrifuged for 10 min at 3,200 g. Supernatant was then discarded and erythrocytes lysed using ACK buffer (ACK Lysing Buffer, Gibco, ThermoFisher Scientific) for 4 min. The samples were then washed with PBS for 10 min at 3200 g. Supernatant was removed and samples containing circulating immune cells and platelets were resuspended in FACS buffer, incubated with anti-FcR antibody (clone 24G2) and stained with the following primary antibodies: Ly6G (clone 1A8), Ly6C (clone AL-21), CD11b (clone M1/70, eBioscience), CD62P (clone RB40.34) and CD41 (clone MWReg30). All antibodies were purchased from BD Pharmingen. After staining samples were washed twice in FACS buffer, fixed for 10 min at 4 °C in 1% paraformaldehyde, washed and resuspended in FACS buffer. The samples were acquired on a Fortessa X20 (BD Pharmingen) and analyzed with FlowJo software (TreeStar).
+ Open protocol
+ Expand
6

Isolation and Immortalization of BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To isolate BMDMs (bone marrow-derived macrophages), tibias and femurs from C57BL/6 or IL-10−/− mice (C57BL/6 background) were removed using sterile techniques, and the bone marrow was flushed with fresh medium. To obtain macrophages, cells were plated in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20% filtered L929 cell supernatant (a source of macrophage colony-stimulating factor) and maintained at 37°C in a humidified atmosphere of 5% CO2. Medium was replaced with fresh supplemental medium after 1 day. After 5 days, BMDMs were immortalized by exposing them for 24 h to the J2 CRE virus (carrying v-myc and v-Raf/v-Mil oncogenes, kindly donated by Avinash R. Shenoy, Imperial College London). This step was repeated 2 days later (day 7), followed by continuous culture in DMEM supplemented with 20% (vol/vol) filtered L929 cell supernatant for 4 to 6 weeks. The presence of a homogeneous population of macrophages was accessed by flow cytometry using antibodies for CD11b (clone M1/70; catalog number 17-0112-82; eBioscience) and CD11c (clone N418; catalog number 48-0114-82; eBioscience).
+ Open protocol
+ Expand
7

Multicolor Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 1 × 106 tissue-derived cells were incubated in PBS supplemented with 2% FCS (PBS-FCS) for 15 min at 4°C prior to the addition of fluorochrome-conjugated monoclonal antibodies specific for CD11b (clone M1/70, eBioscience) CD11c (clone N418, eBioscience), or CD103 (clone 2E7, eBioscience) in PBS-FCS and incubated for 30 min at 4°C in darkness. Cells were then washed in PBS-FCS and fixed in PBS supplemented with 4% paraformaldehyde for 15 min at 20 °C prior to analysis on a MACSQuant Analyzer 10 (Miltenyi Biotech). Data were analysed using FlowJo.
+ Open protocol
+ Expand
8

Peripheral Blood Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry assays were performed as previously described [19 (link)]. Briefly, peripheral blood was collected in tubes containing EDTA and red blood cells lysed with erythrocyte lysing solution (0.15M NH4Cl, 10mM KHCO3, and 1mM EDTA pH 7.3). Cells were stained with monoclonal antibodies recognizing CD4 (clone 02, Sino Biological Inc., Beijing, China), CD8 (clone OKT8, eBioscience, San Diego, CA) CD11b (clone M1/70, eBioscience), CD3 (clone PC3/188A, Santa Cruz Biotechnology, Santa Cruz, CA), and CD79a (clone HM47, eBioscience). Data were acquired on a FACSCanto II flow cytometer (BD Bioscience, San Jose, CA), and analyzed using FlowJo software (Tree Star, Ashland, OR).
+ Open protocol
+ Expand
9

Identification of Thymic ILC Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface staining was performed at 4°C for 30 min in FACS buffer (10% FBS, 2.5mM EDTA in PBS). ILC were identified among CD8α (clone 5.3–6.7, Biolegend), CD3i (clone 17A2, Biolegend), IL‐7Rα+ (clone A7R34, Biolegend), B220 (clone RA3‐6B2, eBioscience), CD11b (clone M1/70, eBioscience), CD11c (clone N418, eBioscience), CD3 (clone 145‐2C11, eBioscience), and CD5 (clone 53–7.3, eBioscience). Thymic iNKT cells were identified as mCD1d/PBS57+ and TCRβ+ (clone H57‐597, eBioscience). Intracellular cell staining was performed at room temperature for 1 h in permeabilization buffer (eBioscience). ILC2 and ILC3 subsets were identified using Abs against GATA3+ (clone TWAJ, eBioscience) and RORγt+ (clone AFKJS‐9, eBioscience). Staining for RANKL expression was performed in two steps using biotinylated RANKL (clone: IK22/5, eBioscience) and streptavidin‐PECy7 (Molecular Probes) at 4°C for 30 min in FACS buffer. Samples included Spherotech Accucount blank particles to enable calculation of cell frequency and were acquired using a Fortessa (BD). Samples were analyzed using FlowJo (FlowJo, LLC). Full gating strategy for all flow cytometry data identifying thymic ILC populations is shown in Supporting Information Fig. 1A.
+ Open protocol
+ Expand
10

Multiparametric Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of 1 × 106 cells were stained with different monoclonal antibodies according to standard protocols. The cells were analyzed on a FACSVerse cytometer (BD Biosciences, San Diego, CA, USA). Fluorescent antibodies of CD45 (clone 30-F-11), CD3ε (clone 145-2C11), CD4 (clone GK1.5), CD83 (clone Michel-19), CD11b (clone M1/70), ly6c(clone HK1.4), F4/80 (clone BM8), B220 (clone RA3-6B2), NK1.1 (clone PK136), MHC-II (clone M5/114.15.2), CD11c (clone N418), CD69 (clone H1.2F3), and Ki67 (clone B56) conjugated with the corresponding fluorescent dyes (eBioscience, San Diego, CA, USA) were used in the experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!